We are live on ! Find out more
BMY.RT

Bristol-Myers Squibb Company Contingent Value Rights
BMY.RT

Delisted

BMY.RT was delisted on the 31st of December, 2020.

616 hedge funds and large institutions have $1.57B invested in Bristol-Myers Squibb Company Contingent Value Rights in 2019 Q4 according to their latest regulatory filings, with 616 funds opening new positions, increasing their positions, reducing their positions, and closing their positions.

New
Increased
Maintained
Reduced
Closed

497% more call options, than puts

Call options by funds: $48M | Put options by funds: $8.03M

Holders
616
Holders Change
+616
Holders Change %
% of All Funds
12.14%
Holding in Top 10
8
Holding in Top 10 Change
+8
Holding in Top 10 Change %
% of All Funds
0.16%
New
616
Increased
Reduced
Closed
Calls
$48M
Puts
$8.03M
Net Calls
+$39.9M
Net Calls Change
+$39.9M
Name Holding Trade Value Shares
Change
Change in
Stake
HDIM
551
Hanson & Doremus Investment Management
Vermont
$1K +$856 +329 New
NFG
552
Next Financial Group
Texas
$1K +$884 +340 New
IAS
553
IMA Advisory Services
Colorado
$1K +$910 +350 New
MWA
554
Meridian Wealth Advisors
Texas
$1K +$962 +370 New
TL
555
TrueWealth LLC
Georgia
$1K +$1.03K +396 New
CAL
556
Capital Analysts LLC
Pennsylvania
$1K +$1.04K +400 New
WOC
557
West Oak Capital
California
$1K +$1.04K +400 New
CIAS
558
Capital Investment Advisory Services
North Carolina
$1K +$1.06K +408 New
SFG
559
Sowa Financial Group
Rhode Island
$1K +$1.07K +410 New
BWA
560
Burt Wealth Advisors
Maryland
$1K +$1.16K +445 New
SIC
561
Salem Investment Counselors
North Carolina
$1K +$1.17K +450 New
PA
562
PSI Advisors
Florida
$1K +$1.2K +461 New
ME
563
McIlrath & Eck
Washington
$1K +$1.27K +488 New
OSNBOA
564
Old Second National Bank of Aurora
Illinois
$1K +$1.28K +492 New
PWMG
565
Prestige Wealth Management Group
New Jersey
$1K +$1.29K +495 New
CSS
566
Cubist Systematic Strategies
Connecticut
$1K +$1.3K +500 New
ACA
567
Aptus Capital Advisors
Alabama
$1K +$1.51K +579 New
QCG
568
Quadrant Capital Group
Ohio
$1K +$2.78K +1,068 New
ECM
569
Estabrook Capital Management
New York
$903 +$780 +300 New
HWA
570
Heritage Wealth Advisors
Virginia
$686 +$593 +228 New
BCWM
571
Bartlett & Co Wealth Management
Ohio
$662 +$572 +220 New
CHAM
572
Clear Harbor Asset Management
Connecticut
$605 +$523 +201 New
WQ
573
Wealth Quarterback
New Jersey
$373 +$322 +124 New
ED
574
Exane Derivatives
France
$98 +$73 +28 New
CT
575
Caldwell Trust
Florida
$24 +$6.33K +2,434 New

BMY.RT Hedge Fund Activity: Q4 2019 in Review

616 of the 5,075 institutional investors tracked by Wall St. Rank reported a position in Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) for Q4 2019, worth a combined $1.57B.

Buyers outnumbered sellers: 616 funds opened new BMY.RT positions and 0 closed out — a net gain of 616 holders — while 0 added to existing stakes and 0 trimmed.

The largest buyer was Laurion Capital Management, opening a new position worth an estimated $130M.

  • 616 institutional investors held Bristol-Myers Squibb Company Contingent Value Rights (BMY.RT) as of Q4 2019, up from 0 in Q3 2019.
  • Funds reported $1.57B of Bristol-Myers Squibb Company Contingent Value Rights stock for Q4 2019.
  • 616 funds opened new Bristol-Myers Squibb Company Contingent Value Rights positions in Q4 2019 and 0 closed out, a net change of +616 holders.
  • The largest Bristol-Myers Squibb Company Contingent Value Rights buyer in Q4 2019 was Laurion Capital Management, an estimated $130M added.

Based on aggregated 13F filings for Q4 2019.